GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease

Autor: Liu, Jingjing, Prager–van der Smissen, Wendy J.C., Look, Maxime P., Sieuwerts, Anieta M., Smid, Marcel, Meijer–van Gelder, Marion E., Foekens, John A., Hollestelle, Antoinette, Martens, John W.M. *
Zdroj: In Cancer Letters 28 June 2016 376(1):104-109
Databáze: ScienceDirect